Skip to main content

Published locations for GLAGOV finds evolocumab plus statin drives unprecedented plaque regression

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. GLAGOV finds evolocumab plus statin drives unprecedented plaque regression

User login

  • Reset your password
  • /content/glagov-finds-evolocumab-plus-statin-drives-unprecedented-plaque-regression
  • /familypracticenews/article/118589/lipid-disorders/glagov-finds-evolocumab-plus-statin-drives
  • /internalmedicinenews/article/118589/lipid-disorders/glagov-finds-evolocumab-plus-statin-drives
  • /clinicalendocrinologynews/article/118589/lipid-disorders/glagov-finds-evolocumab-plus-statin-drives
  • /ecardiologynews/article/118589/lipid-disorders/glagov-finds-evolocumab-plus-statin-drives
  • /cardiology/article/118589/lipid-disorders/glagov-finds-evolocumab-plus-statin-drives-unprecedented
  • /endocrinology/article/118589/lipid-disorders/glagov-finds-evolocumab-plus-statin-drives
  • /internalmedicine/article/118589/lipid-disorders/glagov-finds-evolocumab-plus-statin-drives
  • /familymedicine/article/118589/lipid-disorders/glagov-finds-evolocumab-plus-statin-drives